Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Chronic Lymphocytic Leukemia
100%
Chronic Lymphocytic Leukemia Cells
95%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
57%
Acute Myeloid Leukemia
35%
Activator of Transcription 3
27%
Overall Survival
27%
Leukemia Patients
22%
Prognostic Indicator
21%
Signal Transducer
20%
Chronic Myeloid Leukemia
20%
Cyclophosphamide
20%
Methotrexate
18%
Gene mutation
17%
Prognostic Factors
16%
Apoptosis
16%
Tyrosine Kinase Inhibitor
15%
Infectious Complications
14%
Diffuse Large B-cell Lymphoma (DLBCL)
14%
Febrile Neutropenia
14%
B Cell Receptor
14%
Relapsed/refractory
14%
Chemoimmunotherapy
14%
Long QT Syndrome
14%
Myelodysplastic Syndrome
14%
Survival Benefit
13%
Hematopoietic Cell Transplantation
13%
Fludarabine
13%
Risk Factors
13%
Acute Leukemia
13%
Multiple Myeloma
13%
Clinical Significance
13%
IGHV mutation
13%
Long QT Syndrome Type 3
13%
Ranolazine
13%
BNT162b2 Vaccine
13%
Methotrexate Treatment
13%
Pentraxin 3 (PTX3)
13%
Atrial Fibrillation
13%
Multicenter Observational Study
13%
Midostaurin
13%
Predictive Score
13%
Serological Response
13%
Rituximab
13%
Congenital Long QT Syndrome
13%
Chemotherapy
12%
Protein Expression
12%
Leucine-rich Repeat Kinase 2 (LRRK2)
11%
Parkinson's Disease
11%
Israel
11%
Survival Rate
11%
Immunology and Microbiology
Leukemia Cell
75%
Hematopoietic Cell
61%
STAT3
57%
Cell Transplantation
54%
Overall Survival
29%
Phosphotransferase
25%
Kinase
25%
Myeloid
23%
Programmed Cell Death
23%
Multiple Myeloma
20%
Rituximab
19%
B Cell
16%
Tyrosine
15%
Infectious Disease
15%
Infection
15%
Interleukin 6
15%
Gene Mutation
14%
Drug Megadose
14%
Exosome
13%
Cyclophosphamide
13%
Monoclonal Antibody
13%
Signal Transduction
13%
Methotrexate
13%
B-Cell Receptor
13%
Graft-Versus-Host Disease
13%
Morbidity
12%
Survival Rate
12%
Disease Free Survival
11%
Ribonucleic Acid
10%
Humoral Immunity
10%
Autotransplantation
10%
Engraftment
10%
phosphorylation
9%
CD5
9%
Germ Cell
9%
Intravenous Immunoglobulin
9%
Central Nervous System
9%
T Cell
9%
Promoter Region
9%
Chronic Graft Versus Host Disease
8%
Allogeneic Stem Cell Transplantation
8%
Lipoprotein
8%
Endothelial Cells
8%
Immunoglobulin Heavy Chain Gene
8%
Fatty Acid
7%
C-Reactive Protein
7%
Downregulation
7%
Lymphocyte
7%
Myeloma Cell
6%
Cord Blood Stem Cell Transplantation
6%
Medicine and Dentistry
Hematopoietic Cell
49%
Cell Transplantation
40%
B-Cell Chronic Lymphocytic Leukemia
36%
Acute Myeloid Leukemia
35%
Overall Survival
31%
Tyrosine-Kinase Inhibitor
28%
Chronic Myelogenous Leukemia
27%
Genetics
24%
Methotrexate
20%
Diffuse Large B-Cell Lymphoma
20%
Allogeneic Hematopoietic Stem Cell Transplantation
20%
Neoplasm
20%
Observational Study
20%
Prognostic Factor
18%
Chemotherapy
16%
Diseases
15%
Janus Kinase
14%
Ectopic Pregnancy
13%
Multiple Myeloma
13%
Conception
13%
Antiinfective Agent
13%
Premature Aging
13%
Myeloid metaplasia
13%
Chronic Lymphocytic Leukemia
13%
Midostaurin
13%
Protein Expression
12%
Leukemia
11%
IGHV@
11%
Glioblastoma
10%
Comorbidity
10%
Metastatic Carcinoma
10%
Cytarabine
9%
Clinical Trial
9%
Infectious Complication
9%
Morbidity
9%
Cyclophosphamide
9%
Allele
9%
Tumor
9%
Surgical Technique
8%
Infection
8%
Survival Rate
8%
Elderly Patient
8%
Personal Experience
7%
Personalized Medicine
7%
Quality of Life
7%
Median Follow Up
7%
Primary Tumor
7%
Allogeneic Stem Cell Transplantation
7%
Acute Myelogenous Leukemia
7%
Autotransplantation
7%